Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis

Psychological Medicine
Sarah A HilesJohn Attia

Abstract

Cross-sectional studies support an association between depression and inflammatory markers. However, little is known of their relationship in the context of antidepressant treatment. Our aim was to explore via meta-analysis whether antidepressant treatment is associated with a reduction in three inflammatory markers associated with depression. A computerized search of EMBASE, Medline, PsycINFO and Cochrane Library databases was completed using subject headings for depression and either interleukin-6, C-reactive protein or interleukin-10, selecting studies which reported circulating levels of inflammatory markers before and after antidepressant treatment for people with depression. Outcome and moderator variables were coded for analysis, including inflammatory marker change, depression severity change, age, gender ratio, assay brand, treatment response and weight change. Pooled effect sizes showed a significant decrease in interleukin-6 (n=14, d=-0.42, p=0.02), marginally significant decrease in C-reactive protein (n=8, d=-0.57, p=0.05) and a non-significant decrease in interleukin-10 (n=3, d=-0.45, p=0.14) after treatment. High levels of heterogeneity were observed, which may be associated with clinical variations between the s...Continue Reading

References

Jul 21, 1995·Annals of the New York Academy of Sciences·A SłuzewskaK Wiktorowicz
Sep 24, 1994·BMJ : British Medical Journal·J M Bland, D G Altman
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Feb 11, 1999·The New England Journal of Medicine·C Gabay, I Kushner
Mar 4, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S LanquillonH Vedder
Mar 13, 2001·Annual Review of Immunology·K W MooreA O'Garra
Jun 16, 2001·European Archives of Psychiatry and Clinical Neuroscience·M RothermundtH Kirchner
Jun 22, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·O MikovaM Maes
Sep 22, 2001·Brain, Behavior, and Immunity·E P ZorrillaK Schmidt
Oct 31, 2002·Human Psychopharmacology·Michael Maes
Dec 6, 2002·The International Journal of Neuropsychopharmacology·Gunter Kenis, Michael Maes
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Apr 21, 2005·BMC Medical Research Methodology·Stela Pudar HozoIztok Hozo
May 17, 2005·Journal of Affective Disorders·A John RushMadhukar H Trivedi
Jun 16, 2005·Diabetes Research and Clinical Practice·Hye Soon ParkRina Yu
Jul 14, 2005·Journal of Clinical Psychopharmacology·Arif KhanWalter A Brown
Aug 9, 2005·Biological Psychiatry·Dwight L EvansWilliam J Valvo
Sep 15, 2005·Human Psychopharmacology·Ayse Devrim BasterziErol Göka
May 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Sinead M O'BrienTimothy G Dinan
Mar 16, 2007·Brain, Behavior, and Immunity·Michael R Irwin, Andrew H Miller
Jun 2, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Tye DawoodGavin W Lambert
Sep 23, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·María Eugenia HernándezLenin Pavón
Nov 21, 2008·Clinical and Experimental Pharmacology & Physiology·Gillian M MackayL Gail Darlington
Dec 10, 2008·Stress : the International Journal on the Biology of Stress·Livia A Carvalho, Carmine M Pariante
Jan 20, 2009·Biological Psychiatry·Andrew H MillerCharles L Raison
Feb 4, 2009·Psychosomatic Medicine·M Bryant HowrenJerry Suls
Apr 1, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Reiji YoshimuraJun Nakamura
Dec 18, 2009·Biological Psychiatry·Yekta DowlatiKrista L Lanctôt
Mar 17, 2010·Brain, Behavior, and Immunity·Aoife O'DonovanKevin M Malone
Mar 17, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·L A CarvalhoC M Pariante
Mar 23, 2010·General Hospital Psychiatry·Maurizio BossolaLuigi Tazza
Apr 8, 2010·Human Psychopharmacology·Debbie G A JanssenBernhard T Baune
Jul 16, 2010·Mediators of Inflammation·Bolin CaiLuis Ulloa
Nov 11, 2010·The Journal of Clinical Psychiatry·Alessandro Serretti, Laura Mandelli
Dec 1, 2010·Computational Statistics & Data Analysis·Thaddeus J HaightIra B Tager

❮ Previous
Next ❯

Citations

Sep 20, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Annamaria CattaneoCarmine M Pariante
Dec 19, 2013·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Bethany G EverettS Bryn Austin
May 3, 2014·Social Psychiatry and Psychiatric Epidemiology·David BaumeisterValeria Mondelli
May 6, 2014·Trends in Pharmacological Sciences·Johannes KornhuberErich Gulbins
Mar 7, 2014·Issues in Mental Health Nursing·Deborah Antai-Otong
Jan 7, 2015·Pharmacology & Therapeutics·Sonali ReisingerDaniela D Pollak
Jun 4, 2014·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Peter ManuMarc De Hert
Jul 15, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·R StrawbridgeA J Cleare
Apr 1, 2015·Psychiatry and Clinical Neurosciences·Hiroshi KunugiShintaro Ogawa
Feb 20, 2014·Expert Opinion on Therapeutic Targets·Michael MaesMichael Berk
Apr 18, 2015·Brain, Behavior, and Immunity·Haiyin JiangBing Ruan
Oct 10, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Adrian L LoprestiPeter D Drummond
Dec 4, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Bojana Dunjic-KosticMiroslava Jasovic-Gasic
May 20, 2014·Journal of Affective Disorders·Patricia O Chocano-BedoyaAlberto Ascherio
May 20, 2014·Brain, Behavior, and Immunity·Nicole VogelzangsBrenda W J H Penninx
Sep 8, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Chiara FabbriAlessandro Serretti
Oct 30, 2016·Experimental Gerontology·Paweł NadrowskiKrystyna Kozakiewicz
Nov 1, 2016·Nordic Journal of Psychiatry·Serafim CarvalhoRui Medeiros
Jan 21, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nicole VogelzangsBrenda W J H Penninx
Nov 15, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Maja Pantović-StefanovićMaja Ivković
Jan 13, 2018·International Journal of Molecular Sciences·Manish K Jha, Madhukar H Trivedi
Nov 12, 2017·European Archives of Psychiatry and Clinical Neuroscience·G FondUNKNOWN FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group
Aug 2, 2018·Journal of Women's Health·Marlene P FreemanLee S Cohen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.